Browse by author
Lookup NU author(s): Dr Ana TopfORCiD, Professor Hanns Lochmuller, Professor Rita HorvathORCiD, Dr Andreas Roos
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© 2021 British Neuropathological SocietyAims: MICU1 encodes the gatekeeper of the mitochondrial Ca2+ uniporter, MICU1 and biallelic loss-of-function mutations cause a complex, neuromuscular disorder in children. Although the role of the protein is well understood, the precise molecular pathophysiology leading to this neuropaediatric phenotype has not been fully elucidated. Here we aimed to obtain novel insights into MICU1 pathophysiology. Methods: Molecular genetic studies along with proteomic profiling, electron-, light- and Coherent anti-Stokes Raman scattering microscopy and immuno-based studies of protein abundances and Ca2+ transport studies were employed to examine the pathophysiology of MICU1 deficiency in humans. Results: We describe two patients carrying MICU1 mutations, two nonsense (c.52C>T; p.(Arg18*) and c.553C>T; p.(Arg185*)) and an intragenic exon 2-deletion presenting with ataxia, developmental delay and early onset myopathy, clinodactyly, attention deficits, insomnia and impaired cognitive pain perception. Muscle biopsies revealed signs of dystrophy and neurogenic atrophy, severe mitochondrial perturbations, altered Golgi structure, vacuoles and altered lipid homeostasis. Comparative mitochondrial Ca2+ transport and proteomic studies on lymphoblastoid cells revealed that the [Ca2+] threshold and the cooperative activation of mitochondrial Ca2+ uptake were lost in MICU1-deficient cells and that 39 proteins were altered in abundance. Several of those proteins are linked to mitochondrial dysfunction and/or perturbed Ca2+ homeostasis, also impacting on regular cytoskeleton (affecting Spectrin) and Golgi architecture, as well as cellular survival mechanisms. Conclusions: Our findings (i) link dysregulation of mitochondrial Ca2+ uptake with muscle pathology (including perturbed lipid homeostasis and ER–Golgi morphology), (ii) support the concept of a functional interplay of ER–Golgi and mitochondria in lipid homeostasis and (iii) reveal the vulnerability of the cellular proteome as part of the MICU1-related pathophysiology.
Author(s): Kohlschmidt N, Elbracht M, Czech A, Hausler M, Phan V, Topf A, Huang K-T, Bartok A, Eggermann K, Zippel S, Eggermann T, Freier E, Gross C, Lochmuller H, Horvath R, Hajnoczky G, Weis J, Roos A
Publication type: Article
Publication status: Published
Journal: Neuropathology and Applied Neurobiology
Year: 2021
Volume: 47
Issue: 6
Pages: 840-855
Print publication date: 01/10/2021
Online publication date: 11/01/2021
Acceptance date: 14/09/2020
Date deposited: 09/01/2024
ISSN (print): 0305-1846
ISSN (electronic): 1365-2990
Publisher: Blackwell Publishing Ltd
URL: https://doi.org/10.1111/nan.12694
DOI: 10.1111/nan.12694
Data Access Statement: The proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the data set identifier PXD008867.
PubMed id: 33428302
Altmetrics provided by Altmetric
